Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Amgen Q3 2025 Earnings Call - Repatha's Landmark Data and Robust Pipeline Drive Strong Growth
Amgen reported a robust third quarter with 12% revenue growth and 14% volume increase, fueled by broad-based product momentum and a deep pipeline advancing in four key therapeutic areas. The company a...
- Amgen achieved 12% revenue growth and 14% volume growth in Q3 2025, with 16 products growing double digits.
- Repatha sales surged 40% to $794 million in Q3 and annualize around $3 billion, driven by new Vesalius CV data showing benefits in primary prevention of cardiovascular events.
- Amgen launched Amgen Now, a direct-to-patient platform offering Repatha at roughly 60% below the U.S. list price to bolster patient access and affordability.
- +17 more takeaways
Pinterest Q3 2025 Earnings Call - AI-driven visual search and shopper engagement fuel 17% revenue growth
Pinterest reported a strong third quarter with 17% year-over-year revenue growth to $1.049 billion, driven by 600 million monthly active users and a dominant Gen Z base. The company is evolving into a...
- Pinterest reached 600 million monthly active users, growing 12% year-over-year, with Gen Z as the largest and fastest-growing demographic comprising over 50% of users.
- Q3 revenue grew 17% year-over-year to $1.049 billion, led by retail, telecom, entertainment, and emerging categories like financial services.
- The company is transforming into an AI-powered visual shopping assistant with proprietary multimodal search models and a voice-activated Pinterest Assistant now in beta.
- +9 more takeaways
AmWell Q3 2025 Earnings Call - Advancing AI-Driven Platform to Achieve Cash Flow Break-Even by End of 2026
AmWell delivered Q3 2025 results ahead of expectations, showing progress toward their strategic goal of cash flow break-even by year-end 2026. The company is doubling down on a two-pronged plan: lever...
- Q3 revenue totaled $56.3 million, down 8% YoY, but up 1.3% excluding divested APC business.
- Subscription revenue grew 18% YoY, comprising 55% of total revenue versus 43% a year ago.
- Total visit volume declined 21% to 1.1 million visits, aligned with expectations; normalized visits down 3.5% excluding APC.
- +14 more takeaways
Accel Entertainment Q3 2025 Earnings Call - Strong Sustainable Growth Fueled by Core Market Optimization and Developing Market Expansion
Accel Entertainment reported robust third-quarter 2025 results highlighted by a 9.1% year-over-year revenue increase to $330 million, underpinned by steady growth in core markets Illinois and Montana,...
- Accel Entertainment's Q3 2025 total revenue rose 9.1% year-over-year to $330 million, driven by core market and developing market growth.
- Combined Illinois and Montana markets constitute approximately 82% of revenue, with Illinois revenue up 7% and Montana up 2.1%.
- In Illinois, location optimization continues, focusing on higher-yielding locations with stable or slightly growing machine counts supporting increased revenue per machine.
- +12 more takeaways
Clover Health 3Q 2025 Earnings Call - Growth Amid Margin Pressure as New Member Costs Weigh on Profitability
Clover Health reported solid third quarter 2025 results with 35% Medicare Advantage membership growth and nearly 50% revenue increase year-over-year, sustaining adjusted EBITDA profitability despite r...
- Clover Health grew Medicare Advantage membership 35% year-over-year in Q3 2025 to over 109,000 members and increased insurance revenue by 49%.
- Despite strong growth, adjusted EBITDA was pressured by a larger than expected share of new members who are loss-making in their first year due to marketing, commissions, and medical expenses.
- Returning member cohorts managed by Clover Assistant generate solid contribution profit, which is expected to increase in 2026 as cohorts mature and scale.
- +10 more takeaways
DMC Global Q3 2025 Earnings Call - Strong Balance Sheet Progress Amid Ongoing Market Headwinds
DMC Global reported modest revenue declines across its segments in Q3 2025 but showcased significant progress in strengthening its financial position, cutting net debt by 47% year-to-date to $30.1 mil...
- DMC Global reduced net debt by 47% to $30.1 million through the third quarter, its lowest since acquiring Arcadia.
- Consolidated Q3 sales declined 1% year-over-year to $151.5 million, while adjusted EBITDA rose 51% to $8.6 million.
- Arcadia segment sales increased 7% year-over-year to $61.7 million, with adjusted EBITDA more than doubling due to better operational performance and overhead absorption.
- +7 more takeaways
Toast Q3 2025 Earnings Call - Doubling Market Share on Track with $2B ARR Milestone
Toast delivered a robust Q3 2025 with 34% revenue growth and 35% adjusted EBITDA margins, crossing the $2 billion annual recurring revenue (ARR) mark, doubling ARR in just two years. The company reaff...
- Toast achieved 34% top-line growth and 35% adjusted EBITDA margins in Q3 2025, surpassing $2 billion ARR for the first time, doubling ARR in two years.
- Approximately 95% of ARR stems from core U.S. SMB and mid-market restaurant customers, with net location adds steady year-over-year and win rates vs competitors improving.
- Major client wins include Nordstrom (nearly 200 dining locations), TGI Fridays (U.S. footprint), and Everbowl (100+ units), showcasing platform versatility across restaurant sizes.
- +10 more takeaways
SuRo Capital Q3 2025 Earnings Call - AI Infrastructure Investments Drive Significant NAV Growth
SuRo Capital reported a strong third quarter of 2025, powered by substantial gains in AI infrastructure investments, particularly in CoreWeave, OpenAI, and Vast Data. The firm's net asset value rose t...
- SuRo Capital's net asset value increased to $9.23 per share in Q3 2025, up from $6.73 per share a year earlier, driven by AI infrastructure investments.
- The firm made early, sizable investments in CoreWeave, OpenAI, and Vast Data, which are now core enablers of the AI economy and have appreciated significantly.
- OpenAI restructured in October 2025 to streamline governance and prepare for a potential IPO valued at up to $1 trillion.
- +12 more takeaways
Benchmark Electronics Q3 2025 Earnings Call - Return to Growth Amid Diversified Sector Strengths
Benchmark Electronics reported a solid Q3 2025 performance with revenue of $681 million and non-GAAP EPS of $0.62, hitting the high end of guidance and marking a return to year-over-year growth. The c...
- Benchmark Electronics achieved $681 million revenue in Q3 2025, up 6% sequentially and returning to year-over-year growth.
- Non-GAAP EPS was $0.62, at the high end of company guidance, with gross margins above 10% for the eighth consecutive quarter.
- Double-digit year-over-year revenue growth was reported in medical and aerospace & defense sectors; sequential growth occurred in four of five sectors excluding Semicap.
- +13 more takeaways
Stoke Therapeutics Q3 2025 Earnings Call - Progress and Regulatory Strategy for Zorevunersen in Dravet Syndrome
Stoke Therapeutics reported robust progress on its lead asset zorevunersen, now in a phase 3 Emperor trial targeting Dravet syndrome. With over 200 patients pre-screened and 20 randomized, enrollment ...
- Ian Smith appointed CEO, emphasizing Stoke's transition and growth potential.
- Zorevunersen phase 3 Emperor trial actively recruiting; 200+ patients pre-screened, 20+ randomized.
- Four-year longitudinal data show durable seizure reductions and sustained cognitive and behavioral improvements.
- +13 more takeaways